RAFAEL
DÍAZ DE LA GUARDIA GUERRERO

Investigador en el periodo 1984-2009

Foto de RAFAEL

Foto de Universitat de Barcelona

Universitat de Barcelona

Barcelona, España

Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (7)

2024

Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
HemaSphere, Vol. 8, Núm. 2

2022

The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 6

2021

Engraftment characterization of risk-stratified AML in NSGS mice
Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

2019

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Leukemia, Vol. 33, Núm. 7, pp. 1557-1569

2018

Detection of inflammatory monocytes but not mesenchymal stem/stromal cells in peripheral blood of patients with myelofibrosis
British Journal of Haematology

2017

Proinflammatory signals are insufficient to drive definitive hematopoietic specification of human HSCs in vitro
Experimental Hematology, Vol. 45, pp. 85-93.e2
Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease
Experimental & molecular medicine, Vol. 49, Núm. 2, pp. e290